take on record clarification for price movement
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma responded to BSE's query (dated October 17, 2025) about unusual movement in its share price. The company stated that it has consistently disclosed all material and price-sensitive information to the stock exchange as required under SEBI Listing Regulations. It denied withholding any information that could impact the stock price, and said the recent price movement is purely market-driven with no involvement from the management. The clarification was signed by the Company Secretary, Mohini Hardikbhai Gandhi, on October 18, 2025.
This is a routine clarification with no adverse action or penalty. Short-term, the stock may remain volatile since BSE flagged the price movement, but investors should watch for any follow-up from the exchange or further disclosures from the company.